Study of Antibody-Enzyme Conjugates in Cancer Treatment
Author Information
Author(s): Jackson T L, Lubkin S R, Siemers N O, Kerr D E, Senter P D, Murray J D
Primary Institution: Department of Applied Mathematics, University of Washington
Hypothesis
Can a mathematical model accurately predict the localization of anti-tumour antibody–enzyme conjugates in tumour tissue?
Conclusion
The mathematical model accurately predicts the biodistribution of antibody-enzyme conjugates in tumours.
Supporting Evidence
- The model predictions were compared with experimental observations and an excellent correlation was found.
- Critical parameters affecting conjugate half-life were identified.
- The model was used to examine various dosing strategies for optimal biodistribution.
Takeaway
This study uses math to understand how certain cancer treatments work in the body, showing that the way we give the medicine doesn't change how well it gets to the tumour.
Methodology
A mathematical model was developed and compared with experimental observations to study the biodistribution and pharmacokinetics of antibody-enzyme conjugates.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website